Cargando…
Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
In the middle of the coronavirus disease 19 (COVID-19) outbreak, the main efforts of the scientific community are rightly all focused on identifying efficient pharmacological treatments to cure the acute severe symptoms and developing a reliable vaccine. On the other hand, we cannot exclude that, in...
Autores principales: | Abate, Giulia, Memo, Maurizio, Uberti, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551579/ https://www.ncbi.nlm.nih.gov/pubmed/32839380 http://dx.doi.org/10.3390/healthcare8030286 |
Ejemplares similares
-
Nutrition and AGE-ing: Focusing on Alzheimer's Disease
por: Abate, Giulia, et al.
Publicado: (2017) -
The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease
por: Abate, Giulia, et al.
Publicado: (2020) -
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
por: Abate, Giulia, et al.
Publicado: (2021) -
Post-translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature
por: Clark, James S., et al.
Publicado: (2022) -
A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages
por: Abate, Giulia, et al.
Publicado: (2020)